日本电玻璃公司从2025年开始,在马来西亚生产可再生、低排放的玻璃管,目标是全球生物制药需求。 Nippon Electric Glass starts 2025 with renewable-powered, low-emission glass tubing production in Malaysia, targeting global biopharma demand.

从2025年12月起,日本电玻璃公司将开始在马来西亚大规模生产制药级玻璃管,使用可再生能源发电的全电炉。 Nippon Electric Glass will begin mass production of pharmaceutical-grade glass tubing in Malaysia using an all-electric furnace powered by renewable energy, starting in December 2025. 这标志着世界上首次此类商业经营,比传统方法减少高达90%的二氧化碳排放量。 This marks the world’s first commercial operation of its kind, reducing CO2 emissions by up to 90% compared to traditional methods. 该创新支持对生物制药(包括GLP-1处理)可持续包装的需求不断增长,并旨在达到北美、欧洲和印度及中国等市场的严格环境标准。 The innovation supports rising demand for sustainable packaging in biopharmaceuticals, including GLP-1 treatments, and aims to meet strict environmental standards in North America, Europe, and markets like India and China.